Empire Financial Management Company’s Teva Pharmaceuticals TEVA Stock Holding History

Empire Financial Management Company’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,000	Closed	-$542K	–	208
2026 Q1	$542K	Hold	18,000	–	–	0.12%	150
2025 Q4	$562K	Hold	18,000	–	–	0.12%	148
2025 Q3	$364K	Hold	18,000	–	–	0.08%	169
2025 Q2	$302K	Hold	18,000	–	–	0.09%	167
2025 Q1	$277K	Hold	18,000	–	–	0.09%	177
2024 Q4	$397K	Hold	18,000	–	–	0.12%	155
2024 Q3	$324K	Hold	18,000	–	–	0.1%	172
2024 Q2	$293K	Hold	18,000	–	–	0.1%	173
2024 Q1	$254K	Buy	+18,000	New	+$227K	0.08%	184

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Empire Financial Management Company's TEVA Position: Q2 2026 in Review

Empire Financial Management Company sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 18,000 shares — an estimated $542K sold.

Empire Financial Management Company first reported a position in TEVA in Q1 2024 and held it in 9 quarters. The position peaked at $562K in Q4 2025. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Empire Financial Management Company reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Empire Financial Management Company sold 18,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $542K.
Empire Financial Management Company first reported a position in Teva Pharmaceuticals in Q1 2024 and held it in 9 quarters.
Empire Financial Management Company's Teva Pharmaceuticals position peaked at $562K in Q4 2025.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.